Last reviewed · How we verify
Productos Científicos S. A. de C. V. — Portfolio Competitive Intelligence Brief
1 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Estradiol + Progesterone | Estradiol + Progesterone | marketed | Hormone replacement therapy / Oral contraceptive | Estrogen receptor alpha (ERα), Estrogen receptor beta (ERβ), Progesterone receptor (PR) | Endocrinology / Gynecology |
Therapeutic area mix
- Endocrinology / Gynecology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
Subscribe to ongoing alerts
Every new pipeline event for Productos Científicos S. A. de C. V.:
- Productos Científicos S. A. de C. V. pipeline updates — RSS
- Productos Científicos S. A. de C. V. pipeline updates — Atom
- Productos Científicos S. A. de C. V. pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Productos Científicos S. A. de C. V. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/productos-cient-ficos-s-a-de-c-v. Accessed 2026-05-17.